Loading...
XWARAWM
Market cap3mUSD
Dec 23, Last price  
0.22PLN
1D
-1.79%
1Q
-10.20%
IPO
-88.60%
Name

Airway Medix SA

Chart & Performance

D1W1MN
XWAR:AWM chart
P/E
P/S
1,351.50
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
0.91%
Rev. gr., 5y
-58.03%
Revenues
12k
-87.37%
0057,0000921,000294,000257,0006,00095,00012,000
Net income
-3m
L-91.36%
-1,826,000-1,519,000-2,016,000635,000-2,034,000-1,361,000-2,374,000-7,044,000-37,914,000-3,276,000
CFO
-4m
L+849.10%
-2,007,000-998,000-3,027,000-3,686,000-3,110,0004,983,000-2,248,000-5,853,000-442,000-4,195,000

Profile

Airway Medix S.A. engages in the research, development, and commercialization of disposable devices for the mechanically ventilated patients in the intensive care units and for the patients in life-threatening conditions in the anaesthesiology departments. It offers Closed Suction System, which is designed to clear the endotracheal tube used by the patients that are ventilated mechanically; Oral Care, a system for keeping the hygiene of the mouth cavity of the patients that are intubed and immobilized; and Cuff Pressure Regulator, a system for monitoring and keeping the constant pressure in the cuff of the intubation tube used by the intubaded patient. The company is headquartered in Warsaw, Poland.
IPO date
May 24, 2016
Employees
8
Domiciled in
PL
Incorporated in
PL

Valuation

Title
PLN in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
12
-87.37%
95
1,483.33%
6
-97.67%
Cost of revenue
2,530
2,836
15,315
Unusual Expense (Income)
NOPBT
(2,518)
(2,741)
(15,309)
NOPBT Margin
Operating Taxes
542
(2,325)
Tax Rate
NOPAT
(2,518)
(3,283)
(12,984)
Net income
(3,276)
-91.36%
(37,914)
438.25%
(7,044)
196.71%
Dividends
Dividend yield
Proceeds from repurchase of equity
2,907
BB yield
-16.40%
Debt
Debt current
14,483
7,794
13,228
Long-term debt
6,800
131
Deferred revenue
1,128
1,814
1,457
Other long-term liabilities
1,690
(1,800)
321
Net debt
9,052
9,190
(29,508)
Cash flow
Cash from operating activities
(4,195)
(442)
(5,853)
CAPEX
(130)
Cash from investing activities
(130)
Cash from financing activities
4,848
550
3,713
FCF
(2,388)
(3,324)
2,287
Balance
Cash
5,431
5,404
5,072
Long term investments
37,795
Excess cash
5,430
5,399
42,867
Stockholders' equity
(22,208)
(16,336)
22,727
Invested Capital
26,302
17,592
16,224
ROIC
ROCE
EV
Common stock shares outstanding
61,118
58,418
58,418
Price
0.29
-16.18%
0.35
-52.60%
0.73
-55.76%
Market cap
17,724
-12.31%
20,213
-52.60%
42,645
-55.76%
EV
26,776
29,403
13,137
EBITDA
(2,518)
(2,741)
(15,279)
EV/EBITDA
Interest
2,046
1,377
630
Interest/NOPBT